The Radiotherapy - Adjuvant Versus Early Salvage ( RAVES ) trial is a phase III multicentre randomised controlled trial led by the Trans Tasman Radiation Oncology Group ( TROG ) , in collaboration with the Urological Society of Australia and New Zealand ( USANZ ) , and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group ( ANZUP ) .